Crossmark

Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice

Crossref DOI link: https://doi.org/10.1016/j.reuma.2022.12.003

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de Diego-Sola, Andrea

Castiella Eguzkiza, Agustín

López Domínguez, Luis María

Urreta Barallobre, Iratxe

Sánchez Iturri, María José

Belzunegui Otaño, Joaquín María

Zapata Morcillo, Eva María

Diego-Sola, Andrea de

Eguzkiza, Agustin Castiella

Domínguez, Luis María López

Barallobre, Iratxe Urreta

Iturri, María José Sánchez

Dubuc, Cesar Antonio Egües

Fanlo, Jorge Jesús Cancio

Alonso, Olga Maíz

Jaimes, Jesús Alejandro Valero

Lorenzo, María Vaamonde

Leoz, Leire Samaniego

Otaño, Joaquín Belzunegui

Morcillo, Eva María Zapata
License Information

Text and Data Mining valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2022.12.003

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below